Keyphrases
30-day Readmission
16%
Academic Medical Centers
16%
Adjusted Hazard Ratio
100%
Adjuvant Radiotherapy
16%
Adjuvant Therapy
50%
Clinical Care
16%
Comorbidity
16%
Cox Proportional Hazard Analysis
16%
Definitive Surgery
33%
Disease-free Survival
50%
Disease-specific Survival
50%
Extracapsular Spread
16%
Head-and-neck Cancer
16%
Improved Survival
100%
Log-rank Test
16%
Lymph Node Ratio
16%
Margin Status
16%
Multi-institutional
16%
Multivariable
33%
Neck Dissection
16%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
100%
Overall Survival
50%
Pathological Stage
16%
Patient Compliance
16%
Patient Survival
16%
Post-treatment Surveillance
16%
Previously Untreated
16%
Quality Metrics
16%
Retrospective Cohort
16%
Stage III Disease
16%
Stage IV Disease
16%
Surveillance Metrics
16%
Treatment Verification
16%
Treatment-related
16%
Univariable Analysis
16%
Unplanned Surgery
16%
Medicine and Dentistry
Adjuvant Radiotherapy
16%
Adjuvant Therapy
50%
Comorbidity
16%
Disease Free Survival
50%
Disease Specific Survival
50%
Diseases
16%
Hazard Ratio
100%
Head and Neck Cancer
16%
Log Rank Test
16%
Lymph Node
16%
Neck Dissection
16%
Oral Cavity
100%
Overall Survival
50%
Patient Compliance
16%
Patient Referral
16%
Proportional Hazards Model
16%
Squamous Cell Carcinoma
100%
Pharmacology, Toxicology and Pharmaceutical Science
Comorbidity
25%
Disease Free Survival
75%
Disease Specific Survival
75%
Diseases
25%
Head and Neck Cancer
25%
Overall Survival
75%
Squamous Cell Carcinoma
100%